Variant report

Variant	esv1828570
Chromosome Location	chr6:164528407-164546547
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr6:164528586-164528911	K562	blood:	n/a	n/a
2	ATF3	chr6:164528554-164528863	K562	blood:	n/a	n/a
3	BATF	chr6:164542513-164542855	GM12878	blood:	n/a	n/a
4	BRCA1	chr6:164530874-164531061	H1-hESC	embryonic stem cell:	n/a	n/a
5	CBX3	chr6:164528597-164528861	K562	blood:	n/a	n/a
6	CCNT2	chr6:164530188-164530224	K562	blood:	n/a	n/a
7	CEBPB	chr6:164529897-164530218	IMR90	lung:	n/a	n/a
8	CEBPB	chr6:164528601-164528934	Hela-S3	cervix:	n/a	n/a
9	CEBPB	chr6:164528630-164528930	K562	blood:	n/a	n/a
10	CEBPB	chr6:164546149-164546416	HepG2	liver:	n/a	chr6:164546307-164546318
11	CEBPB	chr6:164530010-164530048	H1-hESC	embryonic stem cell:	n/a	n/a
12	CEBPB	chr6:164529907-164530369	HepG2	liver:	n/a	n/a
13	CEBPB	chr6:164546296-164546354	A549	lung:	n/a	chr6:164546307-164546318
14	CEBPB	chr6:164546183-164546353	H1-hESC	embryonic stem cell:	n/a	chr6:164546307-164546318
15	CEBPB	chr6:164528623-164528896	H1-hESC	embryonic stem cell:	n/a	n/a
16	CEBPB	chr6:164528512-164528986	HCT-116	colon:	n/a	n/a
17	CEBPB	chr6:164529928-164530474	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr6:164528584-164528955	K562	blood:	n/a	n/a
19	CEBPB	chr6:164528552-164528949	K562	blood:	n/a	n/a
20	CEBPB	chr6:164529921-164530172	K562	blood:	n/a	n/a
21	CEBPB	chr6:164528614-164528903	HepG2	liver:	n/a	n/a
22	CEBPB	chr6:164529898-164530224	K562	blood:	n/a	n/a
23	CHD2	chr6:164530362-164530518	Hela-S3	cervix:	n/a	n/a
24	CTCF	chr6:164531400-164531550	HAc	cerebellar:	n/a	n/a
25	CTCF	chr6:164530740-164530890	NHLF	lung:	n/a	n/a
26	CTCF	chr6:164530920-164531070	HCT-116	colon:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
27	CTCF	chr6:164530840-164530990	HEK293	kidney:	n/a	n/a
28	CTCF	chr6:164530620-164530770	GM12864	blood:	n/a	n/a
29	CTCF	chr6:164530916-164531006	MCF-7	breast:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
30	CTCF	chr6:164530931-164531059	Spleen_OC	spleen:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
31	CTCF	chr6:164530900-164531050	GM12878	blood:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
32	CTCF	chr6:164530900-164531050	GM12871	blood:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
33	CTCF	chr6:164530900-164531050	HPAF	blood vessel:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
34	CTCF	chr6:164530882-164531028	NHEK	skin:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
35	CTCF	chr6:164529780-164529930	NB4	blood:	n/a	n/a
36	CTCF	chr6:164530940-164531090	GM06990	blood:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
37	CTCF	chr6:164530940-164531090	HMF	breast:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
38	CTCF	chr6:164530880-164531030	GM12866	blood:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
39	CTCF	chr6:164530860-164531010	GM12872	blood:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
40	CTCF	chr6:164530676-164531224	A549	lung:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
41	CTCF	chr6:164530860-164531010	HepG2	liver:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
42	CTCF	chr6:164530860-164531010	GM12873	blood:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
43	CTCF	chr6:164530880-164531030	AG09309	skin:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
44	CTCF	chr6:164530940-164531023	Pancreas_OC	pancreas:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
45	CTCF	chr6:164530900-164531050	K562	blood:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
46	CTCF	chr6:164530891-164531044	MCF-7	breast:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
47	CTCF	chr6:164530920-164531070	HEK293	kidney:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
48	CTCF	chr6:164530897-164531077	LNCaP	prostate:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
49	CTCF	chr6:164530860-164531010	HVMF	connective:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002
50	CTCF	chr6:164530884-164531038	A549	lung:	n/a	chr6:164530985-164531001 chr6:164530979-164531000 chr6:164530984-164531002

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:164531576-164531626	AG04450	lung:	fetal
2	chr6:164531576-164531626	HRE	kidney:	n/a
3	chr6:164531576-164531626	NB4	blood:	n/a
4	chr6:164531921-164531971	BJ	skin:	n/a
5	chr6:164531576-164531626	AG09309	skin:	n/a
6	chr6:164531921-164531971	SAEC	small airway:	n/a
7	chr6:164531576-164531626	RPTEC	kidney:	n/a
8	chr6:164531576-164531626	ProgFib	skin:	n/a
9	chr6:164531576-164531626	SK-N-SH	brain:	n/a
10	chr6:164531921-164531971	SKMC	muscle:	n/a
11	chr6:164531921-164531971	HMEC	breast:	n/a
12	chr6:164531921-164531971	HCT-116	colon:	n/a
13	chr6:164531576-164531626	HEK293	kidney:	embryo
14	chr6:164531921-164531971	NHDF-neo	bronchial:	n/a
15	chr6:164531576-164531626	HMEC	breast:	n/a
16	chr6:164531576-164531626	PANC-1	pancreas:	n/a
17	chr6:164531576-164531626	Jurkat	blood:	n/a
18	chr6:164531576-164531626	T-47D	breast:	n/a
19	chr6:164531921-164531971	BE2_C	brain:	n/a
20	chr6:164531576-164531626	ovcar-3	ovarian:	n/a
21	chr6:164531576-164531626	BJ	skin:	n/a
22	chr6:164531921-164531971	Hela-S3	cervix:	n/a
23	chr6:164531576-164531626	HL-60	blood:	n/a
24	chr6:164531921-164531971	HPAEpiC	pulmonary alveolar:	n/a
25	chr6:164531576-164531626	SAEC	small airway:	n/a
26	chr6:164531576-164531626	MCF10A-Er-Src	breast:	n/a
27	chr6:164531921-164531971	AoSMC	blood vessel:	n/a
28	chr6:164531921-164531971	A549	lung:	n/a
29	chr6:164531921-164531971	HRE	kidney:	n/a
30	chr6:164531921-164531971	HEK293	kidney:	embryo
31	chr6:164531576-164531626	MCF-7	breast:	n/a
32	chr6:164531576-164531626	SKMC	muscle:	n/a
33	chr6:164531921-164531971	U87	brain:	n/a
34	chr6:164531576-164531626	H1-hESC	embryonic stem cell:	embryo
35	chr6:164531921-164531971	ovcar-3	ovarian:	n/a
36	chr6:164531576-164531626	GM12878	blood:	n/a
37	chr6:164531576-164531626	HIPEpiC	eye:	n/a
38	chr6:164531921-164531971	GM12892	blood:	n/a
39	chr6:164531576-164531626	Caco-2	colon:	n/a
40	chr6:164531576-164531626	HNPCEpiC	eye:	n/a
41	chr6:164531921-164531971	MCF-7	breast:	n/a
42	chr6:164531921-164531971	AG09319	gingival:	n/a
43	chr6:164531576-164531626	U87	brain:	n/a
44	chr6:164531921-164531971	NB4	blood:	n/a
45	chr6:164531576-164531626	LNCaP	prostate:	n/a
46	chr6:164531921-164531971	SK-N-MC	brain:	n/a
47	chr6:164531921-164531971	H1-hESC	embryonic stem cell:	embryo
48	chr6:164531576-164531626	PFSK-1	brain:	n/a
49	chr6:164531576-164531626	HAEpiC	amniotic membrane:	n/a
50	chr6:164531576-164531626	AG10803	skin:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:164542325..164544675-chr6:164545731..164548053,2	K562	blood:
2	chr6:164542325..164544675-chr6:164545731..164548053,2	K562	blood:
3	chr6:163834384..163836526-chr6:164527660..164529288,2	K562	blood:
4	chr6:164527209..164529090-chr6:164549117..164551692,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AL078585.1-7	chr6:164529652-164529793	XLOC_005913
2	lnc-AL078585.1-7	chr6:164530421-164530726	XLOC_005913

Variant related genes	Relation type
ENSG00000230627	TF binding region
ENSG00000230627	CpG island
ENSG00000270419	chromatin interactions
ENSG00000112531	chromatin interactions

Extended variants
information (count: 736 )
Associated
traits (count: 82 )

Variant overlapped rSNPs/rCNVs (count:736 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9456928	chr6:164528407-164528408	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs530294081	chr6:164528427-164528428	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs188880552	chr6:164528519-164528520	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs566591742	chr6:164528548-164528549	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs206703	chr6:164528553-164528554	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs552104523	chr6:164528577-164528578	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs569229672	chr6:164528580-164528581	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs537891670	chr6:164528609-164528610	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs112708388	chr6:164528613-164528614	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs206704	chr6:164528619-164528620	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
11	rs193111447	chr6:164528626-164528627	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs143153956	chr6:164528659-164528660	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs16896136	chr6:164528736-164528737	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs147032959	chr6:164528739-164528740	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs545913427	chr6:164528746-164528747	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs556336665	chr6:164528822-164528823	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs16896138	chr6:164528840-164528841	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs541489423	chr6:164528841-164528842	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs206705	chr6:164528867-164528868	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs530342931	chr6:164528891-164528892	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs373306753	chr6:164528934-164528935	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs540386575	chr6:164528935-164528936	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs560316089	chr6:164528975-164528976	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs532613602	chr6:164528993-164528994	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs552241471	chr6:164529015-164529016	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs59125888	chr6:164529043-164529044	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs35168578	chr6:164529069-164529070	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs531705821	chr6:164529079-164529080	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs548311162	chr6:164529109-164529110	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs568307067	chr6:164529112-164529113	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs534085909	chr6:164529152-164529153	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs535537782	chr6:164529177-164529178	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs56765278	chr6:164529179-164529180	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs117275823	chr6:164529193-164529194	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs114593899	chr6:164529194-164529195	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs527342416	chr6:164529252-164529253	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs116527933	chr6:164529284-164529285	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs541775770	chr6:164529306-164529307	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs184811695	chr6:164529320-164529321	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs187288276	chr6:164529361-164529362	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs3752533	chr6:164529362-164529363	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs540521725	chr6:164529372-164529373	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs3752534	chr6:164529381-164529382	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
44	rs531516061	chr6:164529395-164529396	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs546012788	chr6:164529400-164529401	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs148320236	chr6:164529419-164529420	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs562969200	chr6:164529459-164529460	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs113777007	chr6:164529470-164529471	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs375460550	chr6:164529516-164529517	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs531724165	chr6:164529532-164529533	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:82)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	19435819	CNVD
Ovarian cancer	21720365	CNVD
Glioblastoma multiforme	21138945	CNVD
Ovarian cancer	22355333	CNVD
abnormal development	18461090	CNVD
Epilepsy	22083797	CNVD
Myelofibrosis	22110671	CNVD
chordoma	19801981	CNVD
Myxofibrosarcoma	16751306	CNVD
Autism	17483303	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Acute myeloid leukemia	19651601	CNVD
Sudden cardiac death	19188705	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:174 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:164506400-164530200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr6:164520200-164528600	Weak transcription	Esophagus	oesophagus
3	chr6:164520400-164529200	Weak transcription	Adipose Nuclei	Adipose
4	chr6:164523200-164529400	Weak transcription	Right Atrium	heart
5	chr6:164523200-164530600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
6	chr6:164523400-164536400	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
7	chr6:164524000-164529200	Weak transcription	Brain Substantia Nigra	brain
8	chr6:164524800-164531800	Enhancers	Fetal Muscle Leg	muscle
9	chr6:164526000-164528800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
10	chr6:164527200-164530400	Enhancers	Fetal Muscle Trunk	muscle
11	chr6:164527200-164531600	Enhancers	Fetal Heart	heart
12	chr6:164527400-164529000	Enhancers	Skeletal Muscle Male	skeletal muscle
13	chr6:164527400-164529200	Enhancers	Skeletal Muscle Female	skeletal muscle
14	chr6:164527600-164529400	Weak transcription	Brain Anterior Caudate	brain
15	chr6:164527800-164529600	Enhancers	K562	blood
16	chr6:164528000-164528600	Enhancers	HSMMtube	muscle
17	chr6:164528000-164529000	Weak transcription	Left Ventricle	heart
18	chr6:164528000-164529400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr6:164528000-164529400	Enhancers	HSMM	muscle
20	chr6:164528000-164529600	Weak transcription	Right Ventricle	heart
21	chr6:164528000-164529800	Weak transcription	Brain Hippocampus Middle	brain
22	chr6:164528000-164537200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
23	chr6:164528400-164529600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
24	chr6:164528400-164529600	Enhancers	Psoas Muscle	Psoas
25	chr6:164528400-164530200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
26	chr6:164528600-164528800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
27	chr6:164528600-164528800	Flanking Active TSS	HSMMtube	muscle
28	chr6:164528600-164529200	Enhancers	Esophagus	oesophagus
29	chr6:164528800-164529000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
30	chr6:164528800-164529200	Enhancers	HSMMtube	muscle
31	chr6:164528800-164529800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
32	chr6:164528800-164529800	Enhancers	Muscle Satellite Cultured Cells	--
33	chr6:164528800-164531000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
34	chr6:164529000-164530000	Enhancers	Left Ventricle	heart
35	chr6:164529000-164530200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
36	chr6:164529000-164530200	Enhancers	NH-A	brain
37	chr6:164529000-164531000	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
38	chr6:164529200-164529400	Enhancers	Brain Substantia Nigra	brain
39	chr6:164529200-164529600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
40	chr6:164529200-164529600	Enhancers	Adipose Nuclei	Adipose
41	chr6:164529200-164529600	Enhancers	Liver	Liver
42	chr6:164529200-164529600	Weak transcription	Esophagus	oesophagus
43	chr6:164529200-164530200	Flanking Active TSS	HSMMtube	muscle
44	chr6:164529200-164530600	Enhancers	Spleen	Spleen
45	chr6:164529200-164531200	Enhancers	Primary monocytes fromperipheralblood	blood
46	chr6:164529200-164531200	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
47	chr6:164529400-164529600	Enhancers	Monocytes-CD14+_RO01746	blood
48	chr6:164529400-164529800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
49	chr6:164529400-164529800	Enhancers	Right Atrium	heart
50	chr6:164529400-164530200	Enhancers	Brain Anterior Caudate	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links